ASCLETIS-B (01672.HK): Included in Stock Connect list under Shanghai-Hong Kong and Shenzhen-Hong Kong schemes effective 7 September

NewTimeSpace News: On 7 September 2026, Ascletis Pharma Inc. (stock code: 01672) voluntarily announced that, according to announcements recently published by the Shanghai Stock Exchange and the Shenzhen Stock Exchange, the Company's ordinary shares traded on the Hong Kong Stock Exchange have been included in the eligible securities lists under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect (collectively, "Stock Connect") schemes, both effective from 7 September 2026.

Following the inclusion, eligible Mainland Chinese investors will be able to trade the Company's shares through the Stock Connect channel. The Company believes that the inclusion of its shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect trading mechanisms reflects the market's recognition of the Company's investment value and growth prospects, and expects it to help further broaden its shareholder base, enhance the trading liquidity of its shares, and support the Company's long-term innovation-driven and sustainable development.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.